Fig. 3From: Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patientsBiomarkers modulated in the plasma of female cohorts and associated with aMCI cognitive status and ethnicity. *Biomarkers that were similar across biochemical and algorithmic analysis. Notice the presence of cystatin C and Aβ40 across analysis in White and Hispanic patient cohorts (plasma vs algorithm). aMCI amnestic mild cognitive impairment, PAI.1 plasminogen activator/inhibitorBack to article page